Lindsay Leek

I did a MSc in Bioinformatics and a MSc in Biomolecular sciences. Then, I joinged the Voest group in June 2020 as a PhD student. The focus of my research is to identify biomarkers that determine which cancer patients will benefit from immunotherapy. I aim to realize this objective by elucidating the genotype and phenotype relationship through the integration of genomics, medical images and clinical data in a high-throughput manner.